Acta Veterinaria et Zootechnica Sinica ›› 2020, Vol. 51 ›› Issue (8): 1970-1976.doi: 10.11843/j.issn.0366-6964.2020.08.021

• PREVENTIVE VETERINARY MEDICINE • Previous Articles     Next Articles

Construction of meq Deleted strain by Gene Editing of Marek's Disease Vaccine Strain CVI988/Rispens via the CRISPR/Cas9 System and Identification

YANG Sen1,2,3, TENG Man2,3, LIU Jinling2,3, ZHOU Ziyu1,2,3, ZHENG Luping2,3, CHU Yushu2,3,4, DING Ke1, YU Zuhua1*, LUO Jun2,3*   

  1. 1. Key Laboratory of Animal Disease and Public Safety, College of Animal Science and Technology, Henan University of Science and Technology, Luoyang 471003, China;
    2. Key Laboratory of Animal Immunology, Ministry of Agriculture&Henan Provincial Key Laboratory of Animal Immunology, Henan Academy of Agricultural Sciences, Zhengzhou 450002, China;
    3. UK-China Centre of Excellence for Research on Avian Diseases, Henan Academy of Agricultural Sciences, Zhengzhou 450002, China;
    4. College of Animal Science and Veterinary Medicine, Henan Agricultural University, Zhengzhou 450002, China
  • Received:2020-02-08 Online:2020-08-25 Published:2020-08-19

Abstract: Meq gene is commonly regarded as the main oncogene that plays critical role in the tumorigenesis of Marek's disease (MD). Evolutionarily, there is an obvious sequence difference between the meq genes of vaccine and pathogenic strains with differ virulence. In this study, we have designed the specific guide RNAs (gRNAs) targeting to the meq gene of the vaccine strain CVI988/Rispens, to make the plasmid pX459-gRNA. The CEF cells were transfected with pX459-gRNA plasmids and were infected with CVI988/Rispens virus to produce meq-gene mutated viral particles. Utilizing the CRISPR/Cas9-based gene editing technique, together with the viral plaque purification, PCR analysis, DNA sequencing and indirect immunofluorescence assay (IFA), we successfully generated a meq-deleted mutant named as CVI988Δmeq-C7. Our data provides an important basis for further screening of the monoclonal antibodies against MD vaccine MEQ protein and the development of differential diagnostic reagents.

Key words: Marek's disease, CVI988/Rispens, meq gene, CRISPR/Cas9, gene editing

CLC Number: